Deployment of Early Diagnosis and Mefloquine-Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria Initiative
2006

Early Diagnosis and Treatment of Malaria in Thailand

Sample size: 450000 publication 10 minutes Evidence: high

Author Information

Author(s): Carrara Verena Ilona, Sirilak Supakit, Thonglairuam Janjira, Rojanawatsirivet Chaiporn, Proux Stephane, Gilbos Valery, Brockman Al, Ashley Elizabeth A, McGready Rose, Krudsood Srivicha, Leemingsawat Somjai, Looareesuwan Sornchai, Singhasivanon Pratap, White Nicholas, Nosten François

Primary Institution: Shoklo Malaria Research Unit, Tak, Thailand

Hypothesis

Can early diagnosis and treatment with artesunate-mefloquine reduce malaria cases and deaths in Tak province, Thailand?

Conclusion

The early detection and treatment of malaria significantly reduced morbidity and mortality from multidrug-resistant P. falciparum in Tak province.

Supporting Evidence

  • P. falciparum malaria cases fell by 34% during the TMI period.
  • Hospitalizations for falciparum malaria decreased by 39%.
  • Malaria-related deaths were reduced by 51.5% compared to the previous three years.
  • Cross-sectional surveys indicated a shift to P. vivax as the predominant species in Thai villages.
  • The incidence of falciparum malaria remained low in the displaced persons population.

Takeaway

This study shows that training village volunteers to quickly diagnose and treat malaria can help save lives and reduce sickness in communities.

Methodology

The study involved training village volunteers, improving health facilities, and recording malaria cases before, during, and after the intervention.

Potential Biases

Potential bias due to reliance on self-reported data from health facilities.

Limitations

The study did not account for the impact of cross-border malaria cases from Myanmar.

Participant Demographics

The population included Thai citizens, foreign nationals, and displaced persons, with a focus on ethnic minorities and migrant workers.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI, 33.5–34.4

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030183

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication